查看購物車
  • Simplified Chinese
  • English
2021 - 2031 年醫藥市場規模及預測、全球及地區佔有率、趨勢及成長機會分析報告涵蓋範圍：按分子類型、適應症、產品、類型、配銷通路和地理分類
市場調查報告書
商品編碼
1713230

2021 - 2031 年醫藥市場規模及預測、全球及地區佔有率、趨勢及成長機會分析報告涵蓋範圍：按分子類型、適應症、產品、類型、配銷通路和地理分類

Pharmaceuticals Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Molecule Type, Indication, Product, Type, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 383 Pages | 訂單完成後即時交付

價格

預計醫藥市場規模將從 2024 年的 17,577.8 億美元增至 2031 年的 28,403.0 億美元；預計 2025 年至 2031 年期間市場複合年成長率為 7.1%。推動市場成長的主要因素包括全球疾病負擔增加、對創新治療的需求增加、全球藥品取得管道的擴大以及新興市場的進一步成長，這些都可能在預測期內推動市場發展。然而，監管壓力和市場轉變是市場發展的阻礙因素。

製藥業每年以 6% 的速度成長，這主要是由於患有慢性和嚴重健康疾病的人數不斷增加。糖尿病、肥胖症、癌症和阿茲海默症等疾病的全球負擔持續以驚人的速度上升，推動了對醫療進步的需求。目前全球有1.71億個糖尿病患者，預計到2030年這數字將翻倍。肥胖影響14億人，預計2030年這數字將達到33億人。此外，有1800萬人患有阿茲海默症，到2025年這數字可能會增加到3500萬。

為了應對這些日益嚴重的疾病，製藥公司正在大力投資研發，以創造創新的治療方法。此外，光是義大利的製藥公司每年在臨床試驗上投資就達 7 億歐元（7,574.2 美元），如果算上醫療器材公司，投資額將上升至 10 億歐元（10.8 美元）。公私部門合作夥伴關係 (PPP) 的角色日益增強，這進一步支持了這一點，例如美國國立衛生研究院、美國食品藥物管理局、10 家製藥公司和 5 個非營利組織之間的合作，旨在為 3000 萬名患有罕見疾病的美國人加速基因治療的開發。

新冠疫情的影響也顯著影響了醫藥市場的擴張，預計從 2020 年到 2027 年，市場淨累計成長將達到 5,000 億美元。雖然所有地區的疫苗接種率都已超過第一波水平，但加強劑的使用情況仍然不一致，這給未來疫情的發展帶來了不確定性。對創新藥物的需求將繼續激增，特別是在腫瘤學領域，預計到 2027 年該領域的支出將達到 3,700 億美元，幾乎是目前水準的兩倍。此外，到 2027 年，特種藥物將佔全球支出的 43%，佔已開發市場總支出的 56%。到 2027 年，包括突破性細胞和基因療法在內的生物技術藥物將佔全球支出的 35%，標誌著先進的生物治療學轉變。

比較公司分析根據產品組合（產品滿意度、產品特性和可用性）、近期市場發展（併購、新產品發布和增強、投資和融資、獎勵、協議、合作和夥伴關係、認可和擴張）以及地理位置對醫藥市場進行評估和分類，有助於更好地決策和了解競爭格局。該報告深入探討了全球醫藥市場主要供應商近期的重大發展和創新。主要市場參與者包括強生公司、輝瑞公司、默克公司、禮來公司、百時美施貴寶公司、ESTE​​VE、UCB SA、Teva Pharmaceutical Industries Ltd、Hikma Pharmaceuticals Plc、Viatris Inc、阿斯利康公司、賽諾菲公司、葛蘭素史克維、F. Hoffmann-La Ltd.

根據分子類型，醫藥市場分為小分子、生物和生物相似藥。 2024 年，小分子領域將佔據最大的市場佔有率。根據適應症，醫藥市場分為代謝疾病、癌症、免疫學、呼吸系統疾病、心血管疾病、神經系統疾病、罕見疾病和其他。 2024 年，癌症領域佔據了最大的市場。根據產品，藥品市場分為品牌藥和學名藥。 2024 年，品牌細分市場佔最大佔有率。根據配銷通路，醫藥市場分為醫院藥房、零售藥房、網路藥房。 2024 年，醫院藥局部門佔據最大的市場佔有率。

在製藥市場營運的公司採用各種有機和無機策略。有機策略主要包括產品發布和產品批准。市場上見證的無機成長策略是收購、合作和夥伴關係。這些成長策略使市場參與者能夠擴大業務、增強地理影響力，同時促進整體市場的成長。此外，收購和合作等策略有助於加強他們的客戶群並擴展他們的產品組合。以下列出了醫藥市場主要參與者的一些重大發展。

2025年3月，強生公司旗下的Janssen-Cilag International NV宣布，歐洲藥品管理局人用藥品委員會（CHMP）建議批准擴大DARZALEX（daratumumab）皮下（SC）製劑的適應症。該建議適用於將其與硼替佐米、來那度胺和地塞米松（daratumumab-VRd）聯合用於治療新診斷的多發性骨髓瘤 (NDMM) 成人患者。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：醫藥市場格局

  • 概述
  • PEST分析

第5章：醫藥市場－主要市場動態

  • 醫藥市場－關鍵市場動態
  • 市場促進因素
    • 全球疾病負擔不斷增加，對創新治療的需求不斷增加
    • 擴大全球藥品獲取管道並發展新興市場
  • 市場限制
    • 監管壓力與市場轉變
  • 市場機會
    • 利用創新、人工智慧和市場擴張
  • 未來趨勢
    • 區域權力轉移、供應鏈多元化和監管演變
  • 促進因素和限制因素的影響：

第6章：醫藥市場-全球市場分析

  • 2021-2031年醫藥市場收入
  • 醫藥市場預測分析

第7章：醫藥市場分析－依分子類型

  • 小分子
  • 生物製品和生物相似藥

第 8 章：醫藥市場分析 - 按適應症

  • 代謝性疾病
  • 癌症
  • 免疫學
  • 呼吸系統疾病
  • 心血管疾病
  • 神經系統疾病
  • 罕見疾病
  • 其他

第9章：醫藥市場分析－按產品

  • 品牌
  • 通用的

第 10 章：醫藥市場分析 - 按類型

  • 處方
  • 非處方藥

第 11 章：醫藥市場分析 - 按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 12 章：醫藥市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞士
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 13 章：競爭格局

  • 公司市佔率分析

第 14 章：產業格局

  • 概述
  • 擴張
  • 新產品開發
  • 合併與收購
  • 合作夥伴關係
  • 其他商業策略

第15章：公司簡介

  • Johnson & Johnson
  • Pfizer Inc
  • Merck & Co Inc
  • Eli Lilly and Co
  • Bristol-Myers Squibb Co
  • ESTEVE
  • UCB SA
  • Teva Pharmaceutical Industries Ltd
  • Hikma Pharmaceuticals Plc
  • Viatris Inc
  • AstraZeneca Plc
  • Sanofi SA
  • GSK Plc
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • AbbVie Inc

第 16 章：附錄

Product Code: TIPRE00029839

The pharmaceuticals market is expected to reach US$ 2,840.30 billion by 2031 from US$ 1,757.78 billion in 2024; the market is estimated to grow at a CAGR of 7.1% during 2025-2031. Major factors driving the market growth include rising global disease burden and increasing demand for innovative treatments and expanding global access to medicines and growing emerging markets further are likely to boost the market during the forecast period. However, regulatory pressures and market shifts among the market deterrents.

The pharmaceutical industry regularly grows by 6% every year, primarily due to the increasing number of people suffering from chronic and severe health conditions. The global burden of diseases such as diabetes, obesity, cancer, and Alzheimer's continues to rise at an alarming rate, fueling the need for medical advancements. There are currently 171 million diabetics worldwide, and this figure is expected to double by 2030. Obesity affects 1.4 billion people, and projections estimate that this number will reach 3.3 billion by 2030. Furthermore, 18 million people suffer from Alzheimer's, and the number is likely to increase to 35 million by 2025.

To address these growing illnesses, pharmaceutical companies are investing heavily in research and development research and development to create innovative treatments. Additionally, € 700 million (US$ 757.42) is invested annually in clinical trials by pharma companies in Italy alone, rising to € 1 billion (US$1.08) if medical device companies are included. This is further supported by the increasing role of public-private partnerships (PPPs), such as the collaboration between the National Institutes of Health, the U.S. FDA, 10 pharmaceutical companies, and five non-profit organizations to accelerate gene therapy development for 30 million Americans suffering from rare diseases.

The impact of COVID-19 has also significantly shaped pharmaceutical market expansion, adding an estimated US$ 500 billion in net cumulative market growth from 2020 through 2027. While all regions have exceeded first-wave vaccination rates, booster utilization remains inconsistent, creating uncertainties about the future course of the pandemic. The demand for innovative drugs will continue to surge, particularly in oncology, where spending is projected to reach US$ 370 billion by 2027-almost double the current level. Moreover, specialty medicines will represent 43% of global spending by 2027 and 56% of total spending in developed markets. Biotech medicines, including breakthrough cell and gene therapies, will account for 35% of global spending by 2027, marking a shift toward advanced biotherapeutics.

The comparative company analysis evaluates and categorizes the pharmaceuticals market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global pharmaceuticals market. The key market players are Johnson & Johnson, Pfizer Inc, Merck & Co Inc, Eli Lilly and Co, Bristol-Myers Squibb Co, ESTEVE, UCB SA, Teva Pharmaceutical Industries Ltd, Hikma Pharmaceuticals Plc, Viatris Inc, AstraZeneca Plc, Sanofi SA, GSK PIc, F. Hoffmann-La Roche Ltd, Novartis AG, AbbVie Inc

Based on molecule type, the pharmaceuticals market is segmented into small molecule, biological and biosimilar products. In 2024, the small molecule, segment held the largest share of the market. Based on indication, the pharmaceuticals market is segmented into metabolic diseases, cancer, immunology, respiratory disorder, cardiovascular disorder, neurology disorder, rare disease, others. In 2024, the cancer segment held the largest share of the market. Based on product, the pharmaceuticals market is segmented into branded, generic. In 2024, the branded segment held the largest share of the market. Based on distribution channel, the pharmaceuticals market is segmented into hospital pharmacies, retail pharmacies, online pharmacies. In 2024, the hospital pharmacies segment held the largest share of the market.

Various organic and inorganic strategies are adopted by companies operating in the Pharmaceuticals Market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the Pharmaceuticals Market are listed below.

In March 2025, Janssen-Cilag International NV, a Johnson & Johnson company, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended approval for an expanded indication of DARZALEX (daratumumab) subcutaneous (SC) formulation. This recommendation is for its use in combination with bortezomib, lenalidomide, and dexamethasone (daratumumab-VRd) to treat adults with newly diagnosed multiple myeloma (NDMM).

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Pharmaceutical Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Pharmaceutical Market - Key Market Dynamics

  • 5.1 Pharmaceutical Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Global Disease Burden and Increasing Demand for Innovative Treatments
    • 5.2.2 Expanding Global Access to Medicines and Growing Emerging Markets
  • 5.3 Market Restraints
    • 5.3.1 Regulatory Pressures and Market Shifts
  • 5.4 Market Opportunities
    • 5.4.1 Harnessing Innovation, AI, and Market Expansion
  • 5.5 Future Trends
    • 5.5.1 Regional Power Shifts, Supply Chain Diversification, and Regulatory Evolution
  • 5.6 Impact of Drivers and Restraints:

6. Pharmaceutical Market - Global Market Analysis

  • 6.1 Pharmaceutical Market Revenue (US$ Billion), 2021-2031
  • 6.2 Pharmaceutical Market Forecast Analysis

7. Pharmaceutical Market Analysis - by Molecule Type

  • 7.1 Small Molecule
    • 7.1.1 Overview
    • 7.1.2 Small Molecule: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • 7.2 Biological and Biosimilar Products
    • 7.2.1 Overview
    • 7.2.2 Biological and Biosimilar Products: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)

8. Pharmaceutical Market Analysis - by Indication

  • 8.1 Metabolic Diseases
    • 8.1.1 Overview
    • 8.1.2 Metabolic Diseases: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • 8.2 Cancer
    • 8.2.1 Overview
    • 8.2.2 Cancer: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • 8.3 Immunology
    • 8.3.1 Overview
    • 8.3.2 Immunology: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • 8.4 Respiratory Disorder
    • 8.4.1 Overview
    • 8.4.2 Respiratory Disorder: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • 8.5 Cardiovascular Disorder
    • 8.5.1 Overview
    • 8.5.2 Cardiovascular Disorder: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • 8.6 Neurology Disorder
    • 8.6.1 Overview
    • 8.6.2 Neurology Disorder: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • 8.7 Rare Disease
    • 8.7.1 Overview
    • 8.7.2 Rare Disease: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)

9. Pharmaceutical Market Analysis - by Product

  • 9.1 Branded
    • 9.1.1 Overview
    • 9.1.2 Branded: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.2 Generic
    • 9.2.1 Overview
    • 9.2.2 Generic: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)

10. Pharmaceutical Market Analysis - by Type

  • 10.1 Prescription
    • 10.1.1 Overview
    • 10.1.2 Prescription: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • 10.2 OTC Drugs
    • 10.2.1 Overview
    • 10.2.2 OTC Drugs: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)

11. Pharmaceutical Market Analysis - by Distribution Channel

  • 11.1 Hospital Pharmacies
    • 11.1.1 Overview
    • 11.1.2 Hospital Pharmacies: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • 11.2 Retail Pharmacies
    • 11.2.1 Overview
    • 11.2.2 Retail Pharmacies: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • 11.3 Online Pharmacies
    • 11.3.1 Overview
    • 11.3.2 Online Pharmacies: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)

12. Pharmaceutical Market - Geographical Analysis

  • 12.1 Overview
  • 12.2 North America
    • 12.2.1 North America Pharmaceutical Market Overview
    • 12.2.2 North America: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    • 12.2.3 North America: Pharmaceutical Market Breakdown, by Molecule Type
      • 12.2.3.1 North America: Pharmaceutical Market- Revenue and Forecast Analysis - by Molecule Type
    • 12.2.4 North America: Pharmaceutical Market Breakdown, by Indication
      • 12.2.4.1 North America: Pharmaceutical Market- Revenue and Forecast Analysis - by Indication
    • 12.2.5 North America: Pharmaceutical Market Breakdown, by Product
      • 12.2.5.1 North America: Pharmaceutical Market- Revenue and Forecast Analysis - by Product
    • 12.2.6 North America: Pharmaceutical Market Breakdown, by Type
      • 12.2.6.1 North America: Pharmaceutical Market- Revenue and Forecast Analysis - by Type
    • 12.2.7 North America: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.2.7.1 North America: Pharmaceutical Market- Revenue and Forecast Analysis - by Distribution Channel
    • 12.2.8 North America: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
      • 12.2.8.1 North America: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
      • 12.2.8.2 United States: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.2.8.2.1 United States: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.2.8.2.2 United States: Pharmaceutical Market Breakdown, by Indication
        • 12.2.8.2.3 United States: Pharmaceutical Market Breakdown, by Product
        • 12.2.8.2.4 United States: Pharmaceutical Market Breakdown, by Type
        • 12.2.8.2.5 United States: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.2.8.3 Canada: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.2.8.3.1 Canada: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.2.8.3.2 Canada: Pharmaceutical Market Breakdown, by Indication
        • 12.2.8.3.3 Canada: Pharmaceutical Market Breakdown, by Product
        • 12.2.8.3.4 Canada: Pharmaceutical Market Breakdown, by Type
        • 12.2.8.3.5 Canada: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.2.8.4 Mexico: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.2.8.4.1 Mexico: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.2.8.4.2 Mexico: Pharmaceutical Market Breakdown, by Indication
        • 12.2.8.4.3 Mexico: Pharmaceutical Market Breakdown, by Product
        • 12.2.8.4.4 Mexico: Pharmaceutical Market Breakdown, by Type
        • 12.2.8.4.5 Mexico: Pharmaceutical Market Breakdown, by Distribution Channel
  • 12.3 Europe
    • 12.3.1 Europe Pharmaceutical Market Overview
    • 12.3.2 Europe: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    • 12.3.3 Europe: Pharmaceutical Market Breakdown, by Molecule Type
      • 12.3.3.1 Europe: Pharmaceutical Market- Revenue and Forecast Analysis - by Molecule Type
    • 12.3.4 Europe: Pharmaceutical Market Breakdown, by Indication
      • 12.3.4.1 Europe: Pharmaceutical Market- Revenue and Forecast Analysis - by Indication
    • 12.3.5 Europe: Pharmaceutical Market Breakdown, by Product
      • 12.3.5.1 Europe: Pharmaceutical Market- Revenue and Forecast Analysis - by Product
    • 12.3.6 Europe: Pharmaceutical Market Breakdown, by Type
      • 12.3.6.1 Europe: Pharmaceutical Market- Revenue and Forecast Analysis - by Type
    • 12.3.7 Europe: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.3.7.1 Europe: Pharmaceutical Market- Revenue and Forecast Analysis - by Distribution Channel
    • 12.3.8 Europe: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
      • 12.3.8.1 Europe: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
      • 12.3.8.2 United Kingdom: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.3.8.2.1 United Kingdom: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.3.8.2.2 United Kingdom: Pharmaceutical Market Breakdown, by Indication
        • 12.3.8.2.3 United Kingdom: Pharmaceutical Market Breakdown, by Product
        • 12.3.8.2.4 United Kingdom: Pharmaceutical Market Breakdown, by Type
        • 12.3.8.2.5 United Kingdom: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.3.8.3 Germany: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.3.8.3.1 Germany: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.3.8.3.2 Germany: Pharmaceutical Market Breakdown, by Indication
        • 12.3.8.3.3 Germany: Pharmaceutical Market Breakdown, by Product
        • 12.3.8.3.4 Germany: Pharmaceutical Market Breakdown, by Type
        • 12.3.8.3.5 Germany: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.3.8.4 France: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.3.8.4.1 France: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.3.8.4.2 France: Pharmaceutical Market Breakdown, by Indication
        • 12.3.8.4.3 France: Pharmaceutical Market Breakdown, by Product
        • 12.3.8.4.4 France: Pharmaceutical Market Breakdown, by Type
        • 12.3.8.4.5 France: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.3.8.5 Italy: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.3.8.5.1 Italy: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.3.8.5.2 Italy: Pharmaceutical Market Breakdown, by Indication
        • 12.3.8.5.3 Italy: Pharmaceutical Market Breakdown, by Product
        • 12.3.8.5.4 Italy: Pharmaceutical Market Breakdown, by Type
        • 12.3.8.5.5 Italy: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.3.8.6 Spain: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.3.8.6.1 Spain: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.3.8.6.2 Spain: Pharmaceutical Market Breakdown, by Indication
        • 12.3.8.6.3 Spain: Pharmaceutical Market Breakdown, by Product
        • 12.3.8.6.4 Spain: Pharmaceutical Market Breakdown, by Type
        • 12.3.8.6.5 Spain: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.3.8.7 Switzerland: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.3.8.7.1 Switzerland: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.3.8.7.2 Switzerland: Pharmaceutical Market Breakdown, by Indication
        • 12.3.8.7.3 Spain: Pharmaceutical Market Breakdown, by Product
        • 12.3.8.7.4 Spain: Pharmaceutical Market Breakdown, by Type
        • 12.3.8.7.5 Switzerland: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.3.8.8 Rest of Europe: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.3.8.8.1 Rest of Europe: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.3.8.8.2 Rest of Europe: Pharmaceutical Market Breakdown, by Indication
        • 12.3.8.8.3 Rest of Europe: Pharmaceutical Market Breakdown, by Product
        • 12.3.8.8.4 Rest of Europe: Pharmaceutical Market Breakdown, by Type
        • 12.3.8.8.5 Rest of Europe: Pharmaceutical Market Breakdown, by Distribution Channel
  • 12.4 Asia Pacific
    • 12.4.1 Asia Pacific Pharmaceutical Market Overview
    • 12.4.2 Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    • 12.4.3 Asia Pacific: Pharmaceutical Market Breakdown, by Molecule Type
      • 12.4.3.1 Asia Pacific: Pharmaceutical Market- Revenue and Forecast Analysis - by Molecule Type
    • 12.4.4 Asia Pacific: Pharmaceutical Market Breakdown, by Indication
      • 12.4.4.1 Asia Pacific: Pharmaceutical Market- Revenue and Forecast Analysis - by Indication
    • 12.4.5 Asia Pacific: Pharmaceutical Market Breakdown, by Product
      • 12.4.5.1 Asia Pacific: Pharmaceutical Market- Revenue and Forecast Analysis - by Product
    • 12.4.6 Asia Pacific: Pharmaceutical Market Breakdown, by Type
      • 12.4.6.1 Asia Pacific: Pharmaceutical Market- Revenue and Forecast Analysis - by Type
    • 12.4.7 Asia Pacific: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.4.7.1 Asia Pacific: Pharmaceutical Market- Revenue and Forecast Analysis - by Distribution Channel
    • 12.4.8 Asia Pacific: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
      • 12.4.8.1 Asia Pacific: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
      • 12.4.8.2 China: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.4.8.2.1 China: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.4.8.2.2 China: Pharmaceutical Market Breakdown, by Indication
        • 12.4.8.2.3 China: Pharmaceutical Market Breakdown, by Product
        • 12.4.8.2.4 China: Pharmaceutical Market Breakdown, by Type
        • 12.4.8.2.5 China: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.4.8.3 Japan: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.4.8.3.1 Japan: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.4.8.3.2 Japan: Pharmaceutical Market Breakdown, by Indication
        • 12.4.8.3.3 Japan: Pharmaceutical Market Breakdown, by Product
        • 12.4.8.3.4 Japan: Pharmaceutical Market Breakdown, by Type
        • 12.4.8.3.5 Japan: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.4.8.4 India: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.4.8.4.1 India: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.4.8.4.2 India: Pharmaceutical Market Breakdown, by Indication
        • 12.4.8.4.3 India: Pharmaceutical Market Breakdown, by Product
        • 12.4.8.4.4 India: Pharmaceutical Market Breakdown, by Type
        • 12.4.8.4.5 India: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.4.8.5 Australia: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.4.8.5.1 Australia: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.4.8.5.2 Australia: Pharmaceutical Market Breakdown, by Indication
        • 12.4.8.5.3 Australia: Pharmaceutical Market Breakdown, by Product
        • 12.4.8.5.4 Australia: Pharmaceutical Market Breakdown, by Type
        • 12.4.8.5.5 Australia: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.4.8.6 South Korea: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.4.8.6.1 South Korea: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.4.8.6.2 South Korea: Pharmaceutical Market Breakdown, by Indication
        • 12.4.8.6.3 South Korea: Pharmaceutical Market Breakdown, by Product
        • 12.4.8.6.4 South Korea: Pharmaceutical Market Breakdown, by Type
        • 12.4.8.6.5 South Korea: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.4.8.7 Rest of APAC: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.4.8.7.1 Rest of APAC: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.4.8.7.2 Rest of APAC: Pharmaceutical Market Breakdown, by Indication
        • 12.4.8.7.3 Rest of APAC: Pharmaceutical Market Breakdown, by Product
        • 12.4.8.7.4 Rest of APAC: Pharmaceutical Market Breakdown, by Type
        • 12.4.8.7.5 Rest of APAC: Pharmaceutical Market Breakdown, by Distribution Channel
  • 12.5 Middle East and Africa
    • 12.5.1 Middle East and AfricaPharmaceutical Market Overview
    • 12.5.2 Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    • 12.5.3 Middle East and Africa: Pharmaceutical Market Breakdown, by Molecule Type
      • 12.5.3.1 Middle East and Africa: Pharmaceutical Market- Revenue and Forecast Analysis - by Molecule Type
    • 12.5.4 Middle East and Africa: Pharmaceutical Market Breakdown, by Indication
      • 12.5.4.1 Middle East and Africa: Pharmaceutical Market- Revenue and Forecast Analysis - by Indication
    • 12.5.5 Middle East and Africa: Pharmaceutical Market Breakdown, by Product
      • 12.5.5.1 Middle East and Africa: Pharmaceutical Market- Revenue and Forecast Analysis - by Product
    • 12.5.6 Middle East and Africa: Pharmaceutical Market Breakdown, by Type
      • 12.5.6.1 Middle East and Africa: Pharmaceutical Market- Revenue and Forecast Analysis - by Type
    • 12.5.7 Middle East and Africa: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.5.7.1 Middle East and Africa: Pharmaceutical Market- Revenue and Forecast Analysis - by Distribution Channel
    • 12.5.8 Middle East and Africa: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
      • 12.5.8.1 Middle East and Africa: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
      • 12.5.8.2 South Africa: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.5.8.2.1 South Africa: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.5.8.2.2 South Africa: Pharmaceutical Market Breakdown, by Indication
        • 12.5.8.2.3 South Africa: Pharmaceutical Market Breakdown, by Product
        • 12.5.8.2.4 South Africa: Pharmaceutical Market Breakdown, by Type
        • 12.5.8.2.5 South Africa: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.5.8.3 Saudi Arabia: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.5.8.3.1 Saudi Arabia: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.5.8.3.2 Saudi Arabia: Pharmaceutical Market Breakdown, by Indication
        • 12.5.8.3.3 Saudi Arabia: Pharmaceutical Market Breakdown, by Product
        • 12.5.8.3.4 Saudi Arabia: Pharmaceutical Market Breakdown, by Type
        • 12.5.8.3.5 Saudi Arabia: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.5.8.4 United Arab Emirates: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.5.8.4.1 United Arab Emirates: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.5.8.4.2 United Arab Emirates: Pharmaceutical Market Breakdown, by Indication
        • 12.5.8.4.3 United Arab Emirates: Pharmaceutical Market Breakdown, by Product
        • 12.5.8.4.4 United Arab Emirates: Pharmaceutical Market Breakdown, by Type
        • 12.5.8.4.5 United Arab Emirates: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.5.8.5 Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.5.8.5.1 Rest of Middle East and Africa: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.5.8.5.2 Rest of Middle East and Africa: Pharmaceutical Market Breakdown, by Indication
        • 12.5.8.5.3 Rest of Middle East and Africa: Pharmaceutical Market Breakdown, by Product
        • 12.5.8.5.4 Rest of Middle East and Africa: Pharmaceutical Market Breakdown, by Type
        • 12.5.8.5.5 Rest of Middle East and Africa: Pharmaceutical Market Breakdown, by Distribution Channel
  • 12.6 South and Central America
    • 12.6.1 South and Central AmericaPharmaceutical Market Overview
    • 12.6.2 South and Central America: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    • 12.6.3 South and Central America: Pharmaceutical Market Breakdown, by Molecule Type
      • 12.6.3.1 South and Central America: Pharmaceutical Market- Revenue and Forecast Analysis - by Molecule Type
    • 12.6.4 South and Central America: Pharmaceutical Market Breakdown, by Indication
      • 12.6.4.1 South and Central America: Pharmaceutical Market- Revenue and Forecast Analysis - by Indication
    • 12.6.5 South and Central America: Pharmaceutical Market Breakdown, by Product
      • 12.6.5.1 South and Central America: Pharmaceutical Market- Revenue and Forecast Analysis - by Product
    • 12.6.6 South and Central America: Pharmaceutical Market Breakdown, by Type
      • 12.6.6.1 South and Central America: Pharmaceutical Market- Revenue and Forecast Analysis - by Type
    • 12.6.7 South and Central America: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.6.7.1 South and Central America: Pharmaceutical Market- Revenue and Forecast Analysis - by Distribution Channel
    • 12.6.8 South and Central America: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
      • 12.6.8.1 South and Central America: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
      • 12.6.8.2 Brazil: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.6.8.2.1 Brazil: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.6.8.2.2 Brazil: Pharmaceutical Market Breakdown, by Indication
        • 12.6.8.2.3 Brazil: Pharmaceutical Market Breakdown, by Product
        • 12.6.8.2.4 Brazil: Pharmaceutical Market Breakdown, by Type
        • 12.6.8.2.5 Brazil: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.6.8.3 Argentina: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.6.8.3.1 Argentina: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.6.8.3.2 Argentina: Pharmaceutical Market Breakdown, by Indication
        • 12.6.8.3.3 Argentina: Pharmaceutical Market Breakdown, by Product
        • 12.6.8.3.4 Argentina: Pharmaceutical Market Breakdown, by Type
        • 12.6.8.3.5 Argentina: Pharmaceutical Market Breakdown, by Distribution Channel
      • 12.6.8.4 Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
        • 12.6.8.4.1 Rest of South and Central America: Pharmaceutical Market Breakdown, by Molecule Type
        • 12.6.8.4.2 Rest of South and Central America: Pharmaceutical Market Breakdown, by Indication
        • 12.6.8.4.3 Rest of South and Central America: Pharmaceutical Market Breakdown, by Product
        • 12.6.8.4.4 Rest of South and Central America: Pharmaceutical Market Breakdown, by Type
        • 12.6.8.4.5 Rest of South and Central America: Pharmaceutical Market Breakdown, by Distribution Channel

13. Competitive Landscape

  • 13.1 Company Market Share Analysis

14. Industry Landscape

  • 14.1 Overview
  • 14.2 Expansion
  • 14.3 New Product Development
  • 14.4 Merger and Acquisition
  • 14.5 Partnerships
  • 14.6 Other Business Strategies

15. Company Profiles

  • 15.1 Johnson & Johnson
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Pfizer Inc
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Merck & Co Inc
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Eli Lilly and Co
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Financial Overview
    • 15.4.4 SWOT Analysis
    • 15.4.5 Key Developments
  • 15.5 Bristol-Myers Squibb Co
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 ESTEVE
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 UCB SA
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 Teva Pharmaceutical Industries Ltd
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 Hikma Pharmaceuticals Plc
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Viatris Inc
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments
  • 15.11 AstraZeneca Plc
    • 15.11.1 1Key Facts
    • 15.11.2 Business Description
    • 15.11.3 Products and Services
    • 15.11.4 Financial Overview
    • 15.11.5 SWOT Analysis
    • 15.11.6 Key Developments
  • 15.12 Sanofi SA
    • 15.12.1 Key Facts
    • 15.12.2 Business Description
    • 15.12.3 Products and Services
    • 15.12.4 Financial Overview
    • 15.12.5 SWOT Analysis
    • 15.12.6 Key Developments
  • 15.13 GSK Plc
    • 15.13.1 Key Facts
    • 15.13.2 Business Description
    • 15.13.3 Products and Services
    • 15.13.4 Financial Overview
    • 15.13.5 SWOT Analysis
    • 15.13.6 Key Developments
  • 15.14 F. Hoffmann-La Roche Ltd
    • 15.14.1 Key Facts
    • 15.14.2 Business Description
    • 15.14.3 Products and Services
    • 15.14.4 Financial Overview
    • 15.14.5 SWOT Analysis
    • 15.14.6 Key Developments
  • 15.15 Novartis AG
    • 15.15.1 Key Facts
    • 15.15.2 Business Description
    • 15.15.3 Products and Services
    • 15.15.4 Financial Overview
    • 15.15.5 SWOT Analysis
    • 15.15.6 Key Developments
  • 15.16 AbbVie Inc
    • 15.16.1 Key Facts
    • 15.16.2 Business Description
    • 15.16.3 Products and Services
    • 15.16.4 Financial Overview
    • 15.16.5 SWOT Analysis
    • 15.16.6 Key Developments

16. Appendix

  • 16.1 Glossary of Terms
  • 16.2 About The Insight Partners

List Of Tables

  • Table 1. Pharmaceutical Market Segmentation
  • Table 2. Pharmaceutical Market - Revenue, 2021- 2024 (US$ Billion)
  • Table 3. Pharmaceutical Market - Revenue, 2025- 2031 (US$ Billion)
  • Table 4. Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 5. Pharmaceutical Market - Revenue, 2025 - 2031(US$ Billion) - by Molecule Type
  • Table 6. Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 7. Pharmaceutical Market - Revenue, 2025 - 2031(US$ Billion) - by Indication
  • Table 8. Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 9. Pharmaceutical Market - Revenue, 2025 - 2031(US$ Billion) - by Product
  • Table 10. Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 11. Pharmaceutical Market - Revenue, 2025 - 2031(US$ Billion) - by Type
  • Table 12. Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 13. Pharmaceutical Market - Revenue, 2025 - 2031(US$ Billion) - by Distribution Channel
  • Table 14. North America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type
  • Table 15. North America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 16. North America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication
  • Table 17. North America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 18. North America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Product
  • Table 19. North America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 20. North America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Type
  • Table 21. North America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 22. North America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel
  • Table 23. North America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 24. North America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Country
  • Table 25. North America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Country
  • Table 26. United States: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 27. United States: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 28. United States: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 29. United States: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 30. United States: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 31. United States: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 32. United States: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 33. United States: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 34. United States: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 35. United States: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 36. Canada: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 37. Canada: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 38. Canada: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 39. Canada: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 40. Canada: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 41. Canada: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 42. Canada: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 43. Canada: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 44. Canada: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 45. Canada: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 46. Mexico: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 47. Mexico: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 48. Mexico: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 49. Mexico: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 50. Mexico: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 51. Mexico: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 52. Mexico: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 53. Mexico: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 54. Mexico: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 55. Mexico: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 56. Europe: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type
  • Table 57. Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 58. Europe: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication
  • Table 59. Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 60. Europe: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Product
  • Table 61. Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 62. Europe: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Type
  • Table 63. Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 64. Europe: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel
  • Table 65. Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 66. Europe: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Country
  • Table 67. Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Country
  • Table 68. United Kingdom: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 69. United Kingdom: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 70. United Kingdom: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 71. United Kingdom: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 72. United Kingdom: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 73. United Kingdom: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 74. United Kingdom: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 75. United Kingdom: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 76. United Kingdom: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 77. United Kingdom: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 78. Germany: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 79. Germany: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 80. Germany: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 81. Germany: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 82. Germany: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 83. Germany: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 84. Germany: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 85. Germany: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 86. Germany: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 87. Germany: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 88. France: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 89. France: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 90. France: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 91. France: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 92. France: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 93. France: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 94. France: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 95. France: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 96. France: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 97. France: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 98. Italy: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 99. Italy: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 100. Italy: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 101. Italy: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 102. Italy: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 103. Italy: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 104. Italy: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 105. Italy: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 106. Italy: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 107. Italy: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 108. Spain: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 109. Spain: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 110. Spain: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 111. Spain: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 112. Spain: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 113. Spain: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 114. Spain: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 115. Spain: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 116. Spain: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 117. Spain: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 118. Switzerland: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 119. Switzerland: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 120. Switzerland: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 121. Switzerland: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 122. Switzerland: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 123. Switzerland: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 124. Switzerland: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 125. Switzerland: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 126. Switzerland: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 127. Switzerland: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 128. Rest of Europe: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 129. Rest of Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 130. Rest of Europe: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 131. Rest of Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 132. Rest of Europe: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 133. Rest of Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 134. Rest of Europe: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 135. Rest of Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 136. Rest of Europe: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 137. Rest of Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 138. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type
  • Table 139. Asia Pacific: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 140. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication
  • Table 141. Asia Pacific: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 142. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Product
  • Table 143. Asia Pacific: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 144. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Type
  • Table 145. Asia Pacific: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 146. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel
  • Table 147. Asia Pacific: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 148. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Country
  • Table 149. Asia Pacific: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Country
  • Table 150. China: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 151. China: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 152. China: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 153. China: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 154. China: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 155. China: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 156. China: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 157. China: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 158. China: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 159. China: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 160. Japan: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 161. Japan: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 162. Japan: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 163. Japan: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 164. Japan: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 165. Japan: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 166. Japan: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 167. Japan: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 168. Japan: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 169. Japan: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 170. India: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 171. India: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 172. India: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 173. India: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 174. India: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 175. India: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 176. India: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 177. India: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 178. India: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 179. India: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 180. Australia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 181. Australia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 182. Australia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 183. Australia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 184. Australia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 185. Australia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 186. Australia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 187. Australia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 188. Australia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 189. Australia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 190. South Korea: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 191. South Korea: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 192. South Korea: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 193. South Korea: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 194. South Korea: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 195. South Korea: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 196. South Korea: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 197. South Korea: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 198. South Korea: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 199. South Korea: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 200. Rest of APAC: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 201. Rest of APAC: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 202. Rest of APAC: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 203. Rest of APAC: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 204. Rest of APAC: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 205. Rest of APAC: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 206. Rest of APAC: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 207. Rest of APAC: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 208. Rest of APAC: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 209. Rest of APAC: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 210. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type
  • Table 211. Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 212. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication
  • Table 213. Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 214. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Product
  • Table 215. Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 216. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Type
  • Table 217. Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 218. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel
  • Table 219. Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 220. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Country
  • Table 221. Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Country
  • Table 222. South Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 223. South Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 224. South Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 225. South Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 226. South Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 227. South Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 228. South Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 229. South Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 230. South Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 231. South Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 232. Saudi Arabia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 233. Saudi Arabia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 234. Saudi Arabia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 235. Saudi Arabia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 236. Saudi Arabia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 237. Saudi Arabia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 238. Saudi Arabia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 239. Saudi Arabia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 240. Saudi Arabia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 241. Saudi Arabia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 242. United Arab Emirates: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 243. United Arab Emirates: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 244. United Arab Emirates: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 245. United Arab Emirates: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 246. United Arab Emirates: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 247. United Arab Emirates: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 248. United Arab Emirates: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 249. United Arab Emirates: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 250. United Arab Emirates: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 251. United Arab Emirates: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 252. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 253. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 254. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 255. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 256. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 257. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 258. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 259. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 260. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 261. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 262. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type
  • Table 263. South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 264. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication
  • Table 265. South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 266. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Product
  • Table 267. South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 268. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Type
  • Table 269. South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 270. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel
  • Table 271. South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 272. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Country
  • Table 273. South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Country
  • Table 274. Brazil: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 275. Brazil: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 276. Brazil: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 277. Brazil: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 278. Brazil: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 279. Brazil: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 280. Brazil: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 281. Brazil: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 282. Brazil: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 283. Brazil: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 284. Argentina: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 285. Argentina: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 286. Argentina: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 287. Argentina: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 288. Argentina: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 289. Argentina: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 290. Argentina: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 291. Argentina: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 292. Argentina: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 293. Argentina: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 294. Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
  • Table 295. Rest of South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
  • Table 296. Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
  • Table 297. Rest of South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
  • Table 298. Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
  • Table 299. Rest of South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
  • Table 300. Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
  • Table 301. Rest of South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
  • Table 302. Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
  • Table 303. Rest of South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
  • Table 304. Company Market Share Analysis
  • Table 305. Glossary of Terms, Pharmaceutical Market

List Of Figures

  • Figure 1. Pharmaceutical Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Pharmaceutical Market Revenue (US$ Billion), 2021-2031
  • Figure 5. Pharmaceutical Market Share (%) - by Molecule Type (2024 and 2031)
  • Figure 6. Small Molecule: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 7. Biological and Biosimilar Products: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 8. Pharmaceutical Market Share (%) - by Indication (2024 and 2031)
  • Figure 9. Metabolic Diseases: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 10. Cancer: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 11. Immunology: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 12. Respiratory Disorder: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 13. Cardiovascular Disorder: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 14. Neurology Disorder: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 15. Rare Disease: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 16. Others: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 17. Pharmaceutical Market Share (%) - by Product (2024 and 2031)
  • Figure 18. Branded: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 19. Generic: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 20. Pharmaceutical Market Share (%) - by Type (2024 and 2031)
  • Figure 21. Prescription: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 22. OTC Drugs: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 23. Pharmaceutical Market Share (%) - by Distribution Channel (2024 and 2031)
  • Figure 24. Hospital Pharmacies: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 25. Retail Pharmacies: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 26. Online Pharmacies: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 27. Pharmaceutical Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 28. North America: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 29. North America: Pharmaceutical Market Breakdown, by Molecule Type (2024 and 2031)
  • Figure 30. North America: Pharmaceutical Market Breakdown, by Indication (2024 and 2031)
  • Figure 31. North America: Pharmaceutical Market Breakdown, by Product (2024 and 2031)
  • Figure 32. North America: Pharmaceutical Market Breakdown, by Type (2024 and 2031)
  • Figure 33. North America: Pharmaceutical Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 34. North America: Pharmaceutical Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 35. United States: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 36. Canada: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 37. Mexico: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 38. Europe: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 39. Europe: Pharmaceutical Market Breakdown, by Molecule Type (2024 and 2031)
  • Figure 40. Europe: Pharmaceutical Market Breakdown, by Indication (2024 and 2031)
  • Figure 41. Europe: Pharmaceutical Market Breakdown, by Product (2024 and 2031)
  • Figure 42. Europe: Pharmaceutical Market Breakdown, by Type (2024 and 2031)
  • Figure 43. Europe: Pharmaceutical Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 44. Europe: Pharmaceutical Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 45. United Kingdom: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 46. Germany: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 47. France: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 48. Italy: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 49. Spain: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 50. Switzerland: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 51. Rest of Europe: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 52. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 53. Asia Pacific: Pharmaceutical Market Breakdown, by Molecule Type (2024 and 2031)
  • Figure 54. Asia Pacific: Pharmaceutical Market Breakdown, by Indication (2024 and 2031)
  • Figure 55. Asia Pacific: Pharmaceutical Market Breakdown, by Product (2024 and 2031)
  • Figure 56. Asia Pacific: Pharmaceutical Market Breakdown, by Type (2024 and 2031)
  • Figure 57. Asia Pacific: Pharmaceutical Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 58. Asia Pacific: Pharmaceutical Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 59. China: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 60. Japan: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 61. India: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 62. Australia: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 63. South Korea: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 64. Rest of APAC: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 65. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 66. Middle East and Africa: Pharmaceutical Market Breakdown, by Molecule Type (2024 and 2031)
  • Figure 67. Middle East and Africa: Pharmaceutical Market Breakdown, by Indication (2024 and 2031)
  • Figure 68. Middle East and Africa: Pharmaceutical Market Breakdown, by Product (2024 and 2031)
  • Figure 69. Middle East and Africa: Pharmaceutical Market Breakdown, by Type (2024 and 2031)
  • Figure 70. Middle East and Africa: Pharmaceutical Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 71. Middle East and Africa: Pharmaceutical Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 72. South Africa: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 73. Saudi Arabia: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 74. United Arab Emirates: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 75. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 76. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 77. South and Central America: Pharmaceutical Market Breakdown, by Molecule Type (2024 and 2031)
  • Figure 78. South and Central America: Pharmaceutical Market Breakdown, by Indication (2024 and 2031)
  • Figure 79. South and Central America: Pharmaceutical Market Breakdown, by Product (2024 and 2031)
  • Figure 80. South and Central America: Pharmaceutical Market Breakdown, by Type (2024 and 2031)
  • Figure 81. South and Central America: Pharmaceutical Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 82. South and Central America: Pharmaceutical Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 83. Brazil: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 84. Argentina: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
  • Figure 85. Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)